Estimation of the Size of the Alloreactive NK Cell Repertoire: Studies in Individuals Homozygous for the Group A KIR Haplotype

被引:89
作者
Fauriat, Cyril [1 ]
Andersson, Sandra [1 ]
Bjorklund, Andreas T. [1 ]
Carlsten, Mattias [1 ]
Schaffer, Marie [2 ]
Bjorkstrom, Niklas K. [1 ]
Baumann, Bettina C. [1 ]
Michaelsson, Jakob [1 ]
Ljunggren, Hans-Gustaf [1 ]
Malmberg, Karl-Johan [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden
[2] Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
D O I
10.4049/jimmunol.181.9.6010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Scell transplantation across HLA barriers may trigger NK cell-mediated graft-vs-leukemia effects leading to improved survival for patients with hematological malignancies. However, the genetic algorithm based on killer cell Ig-like receptor (KIR) and HLA genes used to predict NK cell alloreactivity have yielded discrepant results. Accordingly, it has been difficult to define transplantation settings that favor NK cell alloreactivity. In this study, we have used multiparameter flow cytometry to simultaneously analyze the cell surface expression of all four major inhibitory KIR and CD94/NKG2A to determine the size of the alloreactive NK cell repertoires in 31 individuals homozygous for the group A KIR haplotype. We observed a vast variability in the frequencies of cells with an alloreactive potential, ranging from 0 to 62% of the total NK cell population depending on which, and how many, KIR ligands were missing in theoretical recipients. This analysis required a functional examination of KIR3DL2-single positive NK cells, showing that this subset was hyporesponsive in individuals harboring the cognate ligands HLA-A3/A11. The results provide new insights into the variability of the functional alloreactive NK cell repertoire and have implications for donor selection in hematopoietic stem cell transplantation and adoptive NK cell-based immunotherapy. The Journal of Immunology, 2008, 181: 6010-6019.
引用
收藏
页码:6010 / 6019
页数:10
相关论文
共 64 条
[31]   IN SEARCH OF THE MISSING SELF - MHC MOLECULES AND NK CELL RECOGNITION [J].
LJUNGGREN, HG ;
KARRE, K .
IMMUNOLOGY TODAY, 1990, 11 (07) :237-244
[32]   Regulation of immune responses through inhibitory receptors [J].
Long, EO .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :875-904
[33]   NK cell recognition of non-classical HLA class I molecules [J].
López-Botet, M ;
Llano, M ;
Navarro, F ;
Bellón, T .
SEMINARS IN IMMUNOLOGY, 2000, 12 (02) :109-119
[34]   KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation [J].
Malmberg, KJ ;
Schaffer, M ;
Ringdén, O ;
Remberger, M ;
Ljunggren, HG .
MOLECULAR IMMUNOLOGY, 2005, 42 (04) :531-534
[35]   Analysis of HLA-E expression in human tumors [J].
Marín, R ;
Ruiz-Cabello, F ;
Pedrinaci, S ;
Méndez, R ;
Jiménez, P ;
Geraghty, DE ;
Garrido, F .
IMMUNOGENETICS, 2003, 54 (11) :767-775
[36]   Donor-recipient combinations of group A and BKIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation [J].
McQueen, Karina L. ;
Dorighi, Kristel M. ;
Guethlein, Lisbeth A. ;
Wong, Ruby ;
Sanianwala, Bharati ;
Parham, Peter .
HUMAN IMMUNOLOGY, 2007, 68 (05) :309-323
[37]   Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT [J].
Miller, Jeffery S. ;
Cooley, Sarah ;
Parham, Peter ;
Farag, Sherif S. ;
Verneris, Michael R. ;
McQueen, Karina L. ;
Guethlein, Lisbeth A. ;
Trachtenberg, Elizabeth A. ;
Haagenson, Michael ;
Horowitz, Mary M. ;
Klein, John P. ;
Weisdorf, Daniel J. .
BLOOD, 2007, 109 (11) :5058-5061
[38]   P58 MOLECULES AS PUTATIVE RECEPTORS FOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I MOLECULES IN HUMAN NATURAL-KILLER (NK) CELLS - ANTI-P58 ANTIBODIES RECONSTITUTE LYSIS OF MHC CLASS-I-PROTECTED CELLS IN NK CLONES DISPLAYING DIFFERENT SPECIFICITIES [J].
MORETTA, A ;
VITALE, M ;
BOTTINO, C ;
ORENGO, AM ;
MORELLI, L ;
AUGUGLIARO, R ;
BARBARESI, M ;
CICCONE, E ;
MORETTA, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :597-604
[39]   EXISTENCE OF BOTH INHIBITORY (P58) AND ACTIVATORY (P50) RECEPTORS FOR HLA-C MOLECULES IN HUMAN NATURAL-KILLER-CELLS [J].
MORETTA, A ;
SIVORI, S ;
VITALE, M ;
PENDE, D ;
MORELLI, L ;
AUGUGLIARO, R ;
BOTTINO, C ;
MORETTA, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :875-884
[40]   HLA-DR TYPING BY PCR AMPLIFICATION WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) IN 2 HOURS - AN ALTERNATIVE TO SEROLOGICAL DR TYPING IN CLINICAL-PRACTICE INCLUDING DONOR-RECIPIENT MATCHING IN CADAVERIC TRANSPLANTATION [J].
OLERUP, O ;
ZETTERQUIST, H .
TISSUE ANTIGENS, 1992, 39 (05) :225-235